Frank Angella is a control person of Grove Street Advisors and directly owns between 10% and 25% of it. Frank Angella holds a BA in Interdisciplinary Studies from the University of Virginia and an MBA from Harvard Business School.
Grove Street Advisors is an investment adviser based in Newton, MA, registered with the SEC since 2001. It provides investment management. Its clients include pooled investment vehicles. Its regulatory assets under management total $7.14 billion, as filed on 12 May 2026. Its fees, ownership and offices are on the firm’s profile.
Frank Angella is Managing Partner of GroveStreet and a member of its Investment Committee. He joined the firm in 2001 and is responsible for a number of client relationships and leads fund and direct investments across private equity and venture capital in the US and Europe, including healthcare venture capital. Before GroveStreet, he co-founded Biocode Inc., a venture-backed biotech start-up, and earlier was an Analyst in the healthcare group of Advent Venture Partners in London.
- CRD
- 5031049
- Firm
- Grove Street Advisors · CRD 111497
- Role
- Member
- In role since
- July 2005 · 21 years
- Control person
- Yes
- Direct ownership
- 10% to 25%
- Firm headquarters
- Newton, MA
- Individual registration
- No current adviser record · SEC search
- Disciplinary history
- Not yet shown here · SEC record
- Firm bio
- grovestreet.com
Where does Frank Angella work?
Frank Angella has held the title Member at Grove Street Advisors, LLC since July 2005, and is a control person of the firm.
How can I verify Frank Angella’s record?
Frank Angella’s role is listed on Grove Street Advisors, LLC’s Form ADV, which the SEC’s adviser search (adviserinfo.sec.gov) publishes under the firm’s CRD 111497.
Adam BlumensteinVP Finance & Chief Compliance Officer
Mario MirandaMember
Peng (Bruce) OuMember
Christopher QuinnMember & CFO
Patrick SherwoodMember- Christopher YangRetired
- Catherine CrockettRetired
- Clinton HarrisRetired
- Ann St. GermainRetired
- Barry GonderRetired
